News Focus
News Focus
Followers 236
Posts 15397
Boards Moderated 1
Alias Born 03/29/2014

Re: dennisdave post# 753913

Wednesday, 03/12/2025 8:52:47 PM

Wednesday, March 12, 2025 8:52:47 PM

Post# of 810851
I'm just wondering if some of those funds raised in past months also have been spent on the material supply, and subsequent license of the booster agent (most likely Poly ICLC) referenced in the previous Q?

The Company has also completed negotiations and entered into a contract with a company that has an immune booster agent that may have the potential to further increase the potency of DCVax products. The contract provides for material supply and in vitro testing of the booster agent with DCVax products. If the in vitro testing is successful, the parties plan to enter into a license of the booster agent to NWBio. The parties jointly designed the program of experiments, and the experiments were carried out and completed by the Flaskworks team. The parties are now evaluating the results and developing plans for further experiments.
page 28
https://www.sec.gov/ix?doc=/Archives/edgar/data/1072379/000141057824001879/nwbo-20240930x10q.htm



Just wondering.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News